"Jiangsu Hengrui Medicine Co., Ltd. (600276.SH) publishes H-share issuance presentation materials"

Wisdom Financial APP News, Hengrui Medicine (600276.SH) announced that the company is currently conducting related work for issuing offshore listed foreign capital stocks (H shares) and listing on the main board of the Hong Kong Stock Exchange in China. According to the arrangements for this issuance and listing, the company has published the post-hearing materials collection on the Stock Exchange website in accordance with the relevant regulations. The post-hearing materials collection is a draft version, and the information contained therein may be updated and changed in a timely manner.